{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:39:05Z","timestamp":1775018345877,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Human Cytomegalovirus (HCMV) is a ubiquitous virus with a global prevalence of 90%, but infection typically has minimal clinical impact in immunocompetent individuals. Consequently, most people are neither tested nor treated for HCMV. However, HCMV seropositivity is associated with higher hospitalization rates following SARS-CoV-2 infection compared to seronegative individuals, suggesting that viral reactivation may exacerbate severity of clinical symptoms. To investigate this, rhesus macaques naturally infected with rhesus cytomegalovirus (RhCMV) were experimentally inoculated with SARS-CoV-2 and monitored. Following inoculation, RhCMV viral loads in plasma increased from baseline, indicating reactivation. Within tissues, the lungs and ileum expressed immediate early protein-1 (IE1), a marker of active RhCMV infection. Additionally, elevated frequencies of circulating activated CD69<jats:sup>+<\/jats:sup> memory T cells at day 3 suggested a recall response to a previously encountered pathogen. These findings demonstrate RhCMV reactivation and associated immune activation following SARS-CoV-2 infection, highlighting the rhesus macaque\/RhCMV model as a valuable tool to elucidate the role of HCMV in SARS-CoV2 disease in immunocompetent hosts.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1616490","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:22:12Z","timestamp":1750742532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["RhCMV reactivation in SARS-CoV-2 infected aged rhesus macaques"],"prefix":"10.3389","volume":"16","author":[{"given":"Jamin W.","family":"Roh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita S.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara L.","family":"Shacklett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.2c00181","article-title":"Association of COVID-19 with comorbidities: an update","volume":"6","author":"Chatterjee","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/08850666211053990","article-title":"Reactivation of EBV and CMV in severe COVID-19-epiphenomena or trigger of hyperinflammation in need of treatment? A large case series of critically ill patients","volume":"37","author":"Naendrup","year":"2022","journal-title":"J Intensive Care Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4250","article-title":"Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity","volume":"370","author":"Shrock","year":"2020","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.v20:4","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1086\/522433","article-title":"Cytomegalovirus reactivation in \u201cimmunocompetent\u201d patients: a call for scientific prophylaxis","volume":"196","author":"Cook","year":"2007","journal-title":"J Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"B8","first-page":"63","article-title":"Cytomegalovirus cell tropism","volume":"325","author":"Sinzger","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein","year":"2022","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/v14061188","article-title":"Gastrointestinal involvement in SARS-coV-2 infection","volume":"14","author":"Chen","year":"2022","journal-title":"Viruses"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2249940","DOI":"10.1002\/eji.202249940","article-title":"Acute cytomegalovirus infection modulates the intestinal microbiota and targets intestinal epithelial cells","volume":"53","author":"Le-Trilling","year":"2023","journal-title":"Eur J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s13104-016-2181-5","article-title":"Heart failure due to cytomegalovirus myocarditis in immunocompetent young adults: a case report","volume":"9","author":"Magno Palmeira","year":"2016","journal-title":"BMC Res Notes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-224740","article-title":"CMV encephalitis in an immune-competent patient","volume":"2018","author":"Micallef","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-007-0073-y","article-title":"Rhesus CMV: an emerging animal model for human CMV","volume":"197","author":"Powers","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.15.7661-7671.2002","article-title":"Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis","volume":"76","author":"Sequar","year":"2002","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3201\/eid1206.060030","article-title":"Temple monkeys and health implications of commensalism, Kathmandu, Nepal","volume":"12","author":"Jones-Engel","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"B17","article-title":"Development of breeding populations of rhesus macaques (Macaca mulatta) that are specific pathogen-free for rhesus cytomegalovirus","volume":"58","author":"Barry","year":"2008","journal-title":"Comp Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/jmp.12621","article-title":"Horizontal transmission of endemic viruses among rhesus macaques (Macaca mulatta): Implications for human cytomegalovirus vaccine\/challenge design","volume":"52","author":"Yee","year":"2023","journal-title":"J Med Primatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"109942","DOI":"10.1016\/j.celrep.2021.109942","article-title":"Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammation","volume":"37","author":"Verma","year":"2021","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01251-08","article-title":"Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress","volume":"83","author":"Isaacson","year":"2009","journal-title":"J Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-014-3532-9","article-title":"Immediate-Early (IE) gene regulation of cytomegalovirus: IE1- and pp71-mediated viral strategies against cellular defenses","volume":"29","author":"Torres","year":"2014","journal-title":"Virol Sin"},{"key":"B22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijid.2020.04.027","article-title":"Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection","volume":"96","author":"Zhang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.0895","article-title":"Safety and efficacy of antiviral therapy for prevention of cytomegalovirus reactivation in immunocompetent critically ill patients: A randomized clinical trial","volume":"177","author":"Cowley","year":"2017","journal-title":"JAMA Intern Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06716-y","article-title":"Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality","volume":"48","author":"Gatto","year":"2022","journal-title":"Intensive Care Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/idr17010008","article-title":"Cytomegalovirus blood DNAemia in patients with severe SARS-coV-2 pneumonia","volume":"17","author":"Mesland","year":"2025","journal-title":"Infect Dis Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202007-868RL","article-title":"Bronchoalveolar lavage in patients with COVID-19 with invasive mechanical ventilation for acute respiratory distress syndrome","volume":"18","author":"Baron","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of cardiac infection with SARS-coV-2 in confirmed COVID-19 autopsy cases","volume":"5","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.2313","article-title":"Cytomegalovirus (CMV) and acute myocarditis in an immunocompetent patient","volume":"49","author":"Roubille","year":"2010","journal-title":"Intern Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(80)90233-1","article-title":"Cytomegalovirus myocarditis","volume":"100","author":"Wink","year":"1980","journal-title":"Am Heart J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e01346","DOI":"10.1016\/j.idcr.2021.e01346","article-title":"Cytomegalovirus meningoencephalitis in a case of severe COVID-19 Pneumonia","volume":"26","author":"Ananthegowda","year":"2021","journal-title":"A\u00a0Case Rep IDCases"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment","volume":"27","author":"Greene","year":"2024","journal-title":"Nat Neurosci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/v16050785","article-title":"Modulation of paracellular permeability in SARS-coV-2 blood-to-brain transcytosis","volume":"16","author":"Martinez","year":"2024","journal-title":"Viruses"},{"key":"B33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41392-021-00719-9","article-title":"SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00415-023-12092-4","article-title":"Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome","volume":"271","author":"Boesl","year":"2024","journal-title":"J Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12974-021-02339-0","article-title":"Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients","volume":"19","author":"Jarius","year":"2022","journal-title":"J Neuroinflammation"},{"key":"B36","article-title":"Diagnosis of cytomegalovirus infection of the nervous system in AIDS by polymerase chain reaction analysis of cerebrospinal fluid","volume":"99","author":"Cinque","year":"1995","journal-title":"Scand J Infect Dis Suppl"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163669","article-title":"Chronic viral coinfections differentially affect the likelihood of developing long COVID","volume":"133","author":"Peluso","year":"2023","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i13.1255","article-title":"Coronavirus disease-2019 and the intestinal tract: An overview","volume":"27","author":"Alberca","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2534975","DOI":"10.1155\/2021\/2534975","article-title":"Gastrointestinal bleeding in COVID-19 patients: A systematic review with meta-analysis","volume":"2021","author":"Marasco","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e1006202","DOI":"10.1371\/journal.ppat.1006202","article-title":"Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction","volume":"13","author":"Maidji","year":"2017","journal-title":"PloS Pathog"},{"key":"B42","doi-asserted-by":"publisher","first-page":"112419","DOI":"10.1016\/j.biopha.2021.112419","article-title":"Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications","volume":"145","author":"Majidpoor","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41564-020-00841-4","article-title":"Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets","volume":"6","author":"Singh","year":"2021","journal-title":"Nat Microbiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05878-11","article-title":"Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells","volume":"85","author":"Reeves","year":"2011","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000201876.11059.05","article-title":"Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice","volume":"34","author":"Cook","year":"2006","journal-title":"Crit Care Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.12.6620-6636.2003","article-title":"Complete sequence and genomic analysis of rhesus cytomegalovirus","volume":"77","author":"Hansen","year":"2003","journal-title":"J Virol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1086\/jid.1999.179.issue-2","article-title":"Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients","volume":"179","author":"Humar","year":"1999","journal-title":"J Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1086\/655472","article-title":"Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature","volume":"202","author":"van de Berg","year":"2010","journal-title":"J Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1101\/2024.11.14.622799","article-title":"Chronic viral reactivation and associated host immune response and clinical outcomes in acute COVID-19 and post-acute sequelae of COVID-19","author":"Maguire","year":"2024","journal-title":"bioRxiv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1616490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:22:13Z","timestamp":1750742533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1616490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2025.1616490"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1616490","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"1616490"}}